Adial Pharmaceutical, Inc.: Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
Adial Pharmaceutical, Inc.: Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced the appointment of Dr. Jack Reich as Head of Regulatory, effective December 14, 2020. As part of his transition to Company management, Dr. Reich stepped down from the Board of Directors to serve in his new full-time role. Dr. Jack Reich's career spans over 35 years in the pharmaceutical, biotechnology, and venture capital industries. S...
Source: finanznachrichten.de